Tuberculosis: Current implications and management in obstetrics

Obstetrical and Gynecological Survey

Volumn 51, Issue 2, 1996, Pages 115-124

  Robinson, Charlah A ^a   Rose, Nancy C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; STREPTOMYCIN;

BCG VACCINATION; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION PREVENTION; INFECTION RISK; MATERNAL WELFARE; PREVALENCE; REVIEW; RISK FACTOR; SOCIOECONOMICS; TREATMENT PLANNING; TUBERCULOSIS;

DRUG RESISTANCE, MICROBIAL; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TUBERCULOSIS, PULMONARY;

EID: 0030041240     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199602000-00021     Document Type: Review

References (52)

1. Vallejo JG, Starke JR. Tuberculosis and pregnancy. Clin Chest Med 1992;13:693.
2. Brudney K, Dobkin T. Resurgent tuberculosis in New York City: HIV, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745.
3. Center for Disease Control. Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. MMWR Morb Mortal Wkly Rep 1992;41:1.
4. Jereb JA, Kelly GD, Dooley SW et al. Tuberculosis morbidity in the United States: Final data 1990. MMWR Surveill Summ 1991;40:23.
5. Neville K, Bromberg A, Bromberg R et al. The third epidemic - Multi-drug-resistant tuberculosis. Chest 1994;105:45.
6. Novick LF. Tuberculosis in New York City: Rapid rise of a preventable disease. NY State J Med 1992;92(7):293-294.
7. Centers for Disease Control. Prevention and control of tuberculosis among homeless persons: Recommendations of the Advisory Committee on the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1992;41:13.
8. Selwyn PA, Hartel D, Lewis VA et al. A prospective study of the risk of tuberculosis among intravenous-drug users with HIV infection. N Engl J Med 1989;320:545.
9. Center for Disease Control. Tuberculosis and AIDS - New York City. MMWR Morb Mortal Wkly Rep 1987;36:785.
10. Margono F, Mroueh J, Garely A et al. Resurgence of tuberculosis among pregnant women. Obstet Gynecol 1994;83:911.
11. Margono F, Varely A, Mroueh J et al. Epidemiologic notes and reports. MMWR Morb Mortal Wkly Rep 1993;42:605.
12. Bloom BR, Murray CJ. Tuberculosis: Commentary on a reemergent killer. Science 1993;257:1055.
13. Chawla PK, Klapper PJ, Kamholz SL et al. Drug-resistant tuberculosis in an urban population including patients at risk for HIV infection. Am Rev Respir Dis 1992;146:280.
14. Medchill MT, Gillum M. Diagnosis and management of tuberculosis during pregnancy. Obstet Gynecol Surv 1989;44:81.
15. Snider D. Pregnancy and tuberculosis. Chest 1984;86S:10S.
16. Hedvall E. Tuberculosis and pregnancy. Acta Med Scand 1953;148(S286):1.
17. Good JT, Iseman MD, Davidson PT et al. Tuberculosis in association with pregnancy. Am J Obstet Gynecol 1981;140: 492.
18. Pridie RB, Stradling P. Management of pulmonary tuberculosis during pregnancy. Br Med J 1961;3:78.
19. de March PA. Tuberculosis and pregnancy. Chest 1975;68: 800.
20. Schaeffer G, Zervoudakin IA, Fuchs FF et al. Pregnancy and pulmonary tuberculosis. Obstet Gynecol 1975;46:6.
21. Bjerkdal T, Bahna SL, Lehman EH. Course and outcome of pregnancy in women with pulmonary tuberculosis. Scand J Respir Dis 1975;56:245.
22. Daley CL, Small PM, Schecter GF et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992; 326:231.
23. Pape JW, Jean SS, Ho JI et al. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268.
24. Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest 1992;101:1114.
25. Present PA, Comstock GW. Tuberculin sensitivity in pregnancy. Am Rev Respir Dis 1975;112:413.
26. Center for Disease Control. PPD, anergy, and HIV Infection. Guidelines for anergy testing and management of persons at risk of tuberculosis. MMWR CDC Surveill Summ 1991;40:27.
27. Center for Disease Control. The use of BCG vaccines in the control of tuberculosis: A joint statement by the Advisory Council for the Prevention of Infection and the Advisory Council on the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1988;37:663.
28. Swartz HM, Reichling BA. Hazards of radiation exposure for pregnant women. J Am Med Assoc 1978;239:1907.
29. Snider DE, Layde PM, Hohnson MW et al. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980;122:65.
30. Snider DE. Pyridoxine supplementation during isoniazid therapy. Tubercle 1980;61:191.
31. Snider DE, Caras GJ. Isoniazid-associated hepatitis deaths: A review of available information. Am Rev Respir Dis 1992;145: 494.
32. Moulding TS, Redeker AG, Kanel GC. Twenty isoniazid-associated deaths in one state. Am Rev Respir Dis 1989;140: 700.
33. Franks AL, Binkin NJ, Snider DE et al. Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Public Health Rep 1989;104:151.
34. Khuroo MS, Teli MR, Skidmore S et al. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252.
35. Whalley PJ, Adams RH, Combes B. Tetracycline toxicity in pregnancy. J Am Med Assoc 1964;189:5.
36. Mitchell I, Wendon J, Fitt S et al. Antituberculous therapy and acute liver failure. Lancet 1995;345:555.
37. Snider DE. BCG and tuberculin skin tests. J Am Med Assoc 1985;253:3438.
38. Center for Disease Control. Initial therapy for tuberculosis in the era of multiple drug resistance: Recommendations of the Advisory Committee on the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993;42:1.
39. Bobrowitz ID. Ethambutol in pregnancy. Chest 1974;66:20.
40. Snider DE, Powell KE. Should women taking antituberculosis drugs breast-feed? Arch Intern Med 1984;144:589.
41. Cantwell MF, Shehab ZM, Costello AM. Brief Report: Congenital tuberculosis. N Engl J Med 1994;330:1051.
42. De Cock KM, Grant A, Porter JDH. Preventative therapy for tuberculosis in HIV-infected persons: International recommendations, research, and practice. Lancet 1995;345:833.
43. Barnes PF, Bloch AB, Davidson PT et al. Tuberculosis in patients with HIV infection. N Engl J Med 1991;324:1644.
44. Alland D, Kalkut GE, Moss AR et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330:1710.
45. Small PM, Hopewell PC, Singh SP et al. The epidemiology of tuberculosis in San Francisco: A population-based study using conventional and molecular methods. N Engl J Med 1994; 330:1703.
46. Small PM, Shafer RW, Hopewell PC et al. Exogenous reinfection with multidrug-resistant mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328: 1137.
47. Small PM, Schecter GF, Goodman PC et al. Treatment of tuberculosis in patients with advanced . N Engl J Med 1991; 324:289.
48. Patel KB, Belmonte R, Crowe HM. Drug malabsorption and resistant tuberculosis in HIV-infected patients (lettr). N Engl J Med 1995;332:336.
49. Center for Disease Control. Management of persons exposed to multi-drug resistant tuberculosis. MMWR Morb Mortal Wkly Rep 1992;41:61.
50. Passannante MR, Gallagher CT, Reichman LB. Preventative therapy for contacts of multi-drug resistant tuberculosis - A delphi survey. Chest 1994;106:431.
51. Frieden TR, Sterling T, Pablos-Mendez A et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521.
52. Sullivan EA, Kreiswerth B, Palumbo L et al. Emergence of floroquinolone-resistant tuberculosis in New York City. Lancet 1995;345:1148.